BARKER SAM L
Insider CIK 1226877 · LXRX Director · CYCC Director · CADX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2026-06-03 | 2026-06-04 | 89,312 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2026-06-03 | 2026-06-04 | 89,312 | — | $0 | 213,771 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-05-01 | 2026-05-04 | 43,478 | — | $0 | 43,478 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2026-05-01 | 2026-05-04 | 35,714 | — | $0 | 35,714 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-06-03 | 2025-06-03 | 103,806 | — | $0 | 103,806 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2025-06-03 | 2025-06-03 | 89,312 | — | $0 | 89,312 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2025-05-13 | 2025-05-13 | 36,810 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2025-05-13 | 2025-05-13 | 36,810 | — | $0 | 124,459 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-13 | 2024-05-13 | 36,810 | — | $0 | 36,810 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2024-05-13 | 2024-05-13 | 44,906 | — | $0 | 44,906 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2024-04-28 | 2024-04-29 | 8,032 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2024-04-28 | 2024-04-29 | 8,032 | — | $0 | 87,649 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2023-06-30 | 2023-07-03 | 42,438 | — | $0 | 42,438 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2023-06-30 | 2023-07-03 | 21,219 | — | $0 | 40,415 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2023-05-21 | 2023-05-22 | 9,302 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2023-05-21 | 2023-05-22 | 9,302 | — | $0 | 79,617 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-04-28 | 2023-04-28 | 12,658 | — | $0 | 12,658 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2023-04-28 | 2023-04-28 | 8,032 | — | $0 | 8,032 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2022-06-14 | 2022-06-16 | 31,645 | — | $0 | 31,645 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2022-06-14 | 2022-06-16 | 15,822 | — | $0 | 19,196 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-05-21 | 2022-05-23 | 9,302 | — | $0 | 9,302 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2022-05-21 | 2022-05-23 | 14,402 | — | $0 | 14,402 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2022-04-30 | 2022-05-02 | 4,024 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2022-04-30 | 2022-05-02 | 4,024 | — | $0 | 70,315 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | S Sale | 2021-11-30 | 2021-12-02 | 12 | $3.57 | $43 | 3,374 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2021-08-24 | 2021-08-25 | 1,000 | $5.00 | $5.0K | 3,386 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2021-06-15 | 2021-06-17 | 4,748 | — | $0 | 4,748 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award | 2021-06-15 | 2021-06-17 | 2,374 | — | $0 | 2,386 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-04-30 | 2021-05-03 | 6,475 | — | $0 | 6,475 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2021-04-30 | 2021-05-03 | 4,024 | — | $0 | 4,024 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2021-04-24 | 2021-04-27 | 10,638 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2021-04-24 | 2021-04-27 | 10,638 | — | $0 | 66,291 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2020-06-25 | 2020-06-29 | 5,200 | — | $0 | 5,200 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise deriv | 2020-04-26 | 2020-04-27 | 3,466 | — | $0 | 0 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | M Exercise | 2020-04-26 | 2020-04-27 | 3,466 | — | $0 | 55,653 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-04-24 | 2020-04-27 | 10,638 | — | $0 | 10,638 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2020-04-24 | 2020-04-27 | 18,115 | — | $0 | 18,115 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-02 | 2019-08-02 | 12,000 | $1.18 | $14.2K | 52,187 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2019-08-02 | 2019-08-02 | 12,000 | $1.17 | $14.0K | 40,187 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2019-05-29 | 2019-05-31 | 18,750 | — | $0 | 18,750 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-04-26 | 2019-04-29 | 6,519 | — | $0 | 6,519 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2019-04-26 | 2019-04-29 | 3,466 | — | $0 | 3,466 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2018-05-31 | 2018-06-04 | 8,576 | — | $0 | 8,576 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2018-04-27 | 2018-04-27 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2018-04-27 | 2018-04-27 | 2,564 | — | $0 | 28,187 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | P Buy | 2017-09-15 | 2017-09-18 | 1,000 | $12.50 | $12.5K | 25,623 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2017-05-30 | 2017-06-01 | 2,000 | — | $0 | 2,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2017-04-28 | 2017-05-01 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2017-04-28 | 2017-05-01 | 1,281 | — | $0 | 24,623 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2016-05-26 | 2016-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2016-04-29 | 2016-05-02 | 2,857 | — | $0 | 2,857 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2016-04-29 | 2016-05-02 | 1,432 | — | $0 | 23,342 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2015-05-22 | 2015-05-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2015-04-24 | 2015-04-24 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2015-04-24 | 2015-04-24 | 18,691 | — | $0 | 153,376 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | P Buy | 2014-11-20 | 2014-11-20 | 3,100 | $3.00 | $9.3K | 3,100 | SEC↗ |
| CYCC Cyclacel Pharmaceuticals, | A Award deriv | 2014-09-10 | 2014-09-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2014-04-25 | 2014-04-29 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2014-04-25 | 2014-04-29 | 12,820 | — | $0 | 134,685 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.63 | $57.9K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 17,500 | $11.02 | $192.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $4.75 | $59.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $6.84 | $85.5K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 25,000 | $6.79 | $169.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $7.65 | $95.6K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 12,500 | $1.70 | $21.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 25,000 | $10.80 | $270.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 20,000 | $14.00 | $280.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-06-12 | 2013-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2013-05-10 | 2013-05-13 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2013-05-10 | 2013-05-13 | 10,101 | — | $0 | 121,865 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-06-13 | 2012-06-14 | 17,500 | — | $0 | 17,500 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award deriv | 2012-04-27 | 2012-04-27 | 20,000 | — | $0 | 20,000 | SEC↗ |
| LXRX LEXICON PHARMACEUTICALS, I | A Award | 2012-04-27 | 2012-04-27 | 11,764 | — | $0 | 111,764 | SEC↗ |